MicroPort<sup>®</sup> Awarded "2016 National Model Academicians and Experts Workstation"

Shanghai, China – On December 28, the Academicians and Experts Workstation of Shanghai MicroPort Medical (Group) Co., Ltd. ("MicroPort®") was awarded "2016 Shanghai Outstanding Academicians and Experts Workstation" and selected as "2016 National Model Academicians and Experts Workstation," and received the certificates and a bronze medal during the 2016 Shanghai Academicians and Experts Workstation Conference.
 
Established on December 2, 2009, MicroPort® Academicians and Experts Workstation is the first of its kind in Pudong of Shanghai, and its members include Academician Weiqi Wang and Academician Kerong Dai of Chinese Academy of Engineering. Since establishment, MicroPort® Academicians and Experts Workstation actively organizes forums with domestic universities to provide a platform for experts to seek inspirations for innovation and commercialization of technological achievements by face-to-face communication. In 2014, MicroPort® Academicians and Experts Workstation was awarded "Shanghai Outstanding Academicians and Experts Workstation" for the year, and this time it was awarded "2016 National Model Academicians and Experts Workstation,", which fully demonstrated the recognition of government and industry in the achievement made by MicroPort® Academicians and Experts Workstation.
 
Driven by the Academicians and Experts Workstation, MicroPort® closely works with experts and together with them developed several innovative products, such as WILLIS® Intracranial Stent Graft System ("WILLIS®"), which was jointly developed with Professor Minghua Li of Shanghai Sixth People's Hospital, and Tubridge™ Vascular Reconstruction Device ("Tubridge™"), which was jointly developed with Professor Jianmin Liu of Shanghai Changhai Hospital. In particular, WILLIS® is the first stent-graft system indicated for the treatment of intracranial aneurysms that has gained market approval in China. Besides, a research project "Research and Clinical Application of Noninvasive Imaging and Minimally Invasive Treatment of Intracranial Aneurysm and its Related Vascular," based on the clinical application of WILLIS®, was granted the second-class award of Science and Technology Achievements of the Year 2014. In 2016, Tubridge™ was granted the Green-Path by the China Food and Drug Administration ("CFDA"), a special fast-track procedure for innovative medical devices to gain CFDA approval. In the future, MicroPort® Academicians and Experts Workstation will continue to build a platform for medical device talents, enabling them to take advantage of high-end technologies to develop innovative devices and promote the development of technological achievement commercialization.